Disruption18 May 2026, 12:11 pm
Akums Resumes Haridwar Operations; ₹20 Cr Impact
AI Summary
Akums Drugs and Pharmaceuticals Ltd announced the resumption of 100% operations at its Haridwar manufacturing sites, effective May 18, 2026, following a four-day disruption. The disruption resulted in a delayed supply of approximately ₹20 Cr. The company anticipates recovering the production loss in the coming weeks and will not be filing any insurance claims related to the disruption.
Key Highlights
- Akums resumes 100% operations at Haridwar sites on May 18, 2026.
- Four-day disruption caused delayed supply of approximately ₹20 Cr.
- Company expects to recover production loss in coming weeks.
- No insurance claim will be filed for the operational disruption.